Kissei Pharmaceutical Co (TSE:4547) Change In Receivables : 円0 Mil (TTM As of Dec. 2023)

View and export this data going back to 1988. Start your Free Trial

What is Kissei Pharmaceutical Co Change In Receivables?

Kissei Pharmaceutical Co's change in receivables for the quarter that ended in Dec. 2023 was 円0 Mil. It means Kissei Pharmaceutical Co's Accounts Receivable stayed the same from Sep. 2023 to Dec. 2023 .

Kissei Pharmaceutical Co's change in receivables for the fiscal year that ended in Mar. 2024 was 円-5,863 Mil. It means Kissei Pharmaceutical Co's Accounts Receivable increased by 円5,863 Mil from Mar. 2023 to Mar. 2024 .

Kissei Pharmaceutical Co's Accounts Receivable for the quarter that ended in Dec. 2023 was 円29,501 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Kissei Pharmaceutical Co's Days Sales Outstanding for the three months ended in Dec. 2023 was 128.92.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Kissei Pharmaceutical Co's liquidation value for the three months ended in Dec. 2023 was 円46,701 Mil.

Kissei Pharmaceutical Co Change In Receivables Historical Data

The historical data trend for Kissei Pharmaceutical Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kissei Pharmaceutical Co Change In Receivables Chart

Kissei Pharmaceutical Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Change In Receivables

Get a 7-Day Free Trial

7,500.00

-3,595.00

250.00

27.00

-5,863.00

Kissei Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Kissei Pharmaceutical Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

Kissei Pharmaceutical Co (TSE:4547) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Kissei Pharmaceutical Co's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	29501	/	20881	*	91
=	128.92

2. In Ben Graham's calculation of liquidation value, Kissei Pharmaceutical Co's accounts receivable are only considered to be worth 75% of book value:

Kissei Pharmaceutical Co's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	43205	-	30863	+	0.75 * 29501	+	0.5 * 24467
=	46,701

Kissei Pharmaceutical Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Kissei Pharmaceutical Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Kissei Pharmaceutical Co (TSE:4547) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kissei Pharmaceutical Co Ltd (TSE:4547) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

KSPHF:USA

Address

19-48, Yoshino, Matsumoto City, Nagano, JPN, 399-8710

Website

http://www.kissei.co.jp

Kissei Pharmaceutical Co Ltd is a specialty and generic drug manufacturing company. Pharmaceuticals is the company's reportable segment. The company's operations span across the globe, while the vast majority of revenue is generated in Japan, followed by Europe. Kissei operates a variety of subsidiaries. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Kissei Pharmaceutical Co (TSE:4547) Headlines

No Headlines